Vyndamax 61 MG capsule UD 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F9PB1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,593
Award facts
- Contract value 100% obligated
- $14,592.57 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,592.57 to AmerisourceBergen Drug Corp for the supply of Vyndamax 61 mg capsule unit dose packages (30-count) with a firm fixed price structure. This is a non-set-aside, competitively awarded contract with a place of performance in Conshohocken, Pennsylvania, and an ultimate completion date of February 24, 2026. The award was issued on February 2, 2026, and represents a single delivery order under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government.
This delivery order is executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 through December 2026. The parent company, Cencora, Inc. (doing business as AmerisourceBergen), maintains this comprehensive global pharmaceutical support vehicle that enables supply of a wide range of medications, vaccines, and medical supplies to military healthcare programs and other federal medical institutions. Vyndamax is a prescription medication used in the treatment of transthyretin amyloidosis, demonstrating AmerisourceBergen's role as a critical vendor for specialized pharmaceutical commodities within the military healthcare supply chain.
Quick answers
Who was awarded contract SPE2DR26F9PB1?
SPE2DR26F9PB1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 2, 2026.
How much is contract SPE2DR26F9PB1 worth?
The government has obligated $14,593 on SPE2DR26F9PB1.
Is contract SPE2DR26F9PB1 an order under another contract?
Yes. SPE2DR26F9PB1 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9PB1 competed?
The extent of competition for SPE2DR26F9PB1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award